$4.55
0.14[3.17%]
At close: May 3
$4.55
0[0.00%]
After Hours: 7:44PM EDT
Vistagen Therapeutics
(NASDAQ:VTGN)Latest News for Vistagen Therapeutics Stock (NASDAQ:VTGN)
Vistagen Therapeutics Stock (NASDAQ: VTGN)
Categories: All
Thursday, April 25, 2024
Monday, April 01, 2024
Monday, February 19, 2024
Tuesday, February 13, 2024
Monday, February 12, 2024
Wednesday, December 27, 2023
Thursday, December 07, 2023
Wednesday, December 06, 2023
Monday, December 04, 2023
Tuesday, November 14, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Tuesday, October 17, 2023
Monday, October 16, 2023
Thursday, October 05, 2023
Monday, October 02, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Oct 2, 2023, 1:30PM
- Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 2, 2023, 1:00PM
- Vistagen Therapeutics Has Priced A $100M Underwritten Offering Of Its Common Stock And Warrants At A Combined Purchase Price Of $5.38/Share, Accompanying T1 Warrant And Accompanying T2 WarrantBenzinga Newsdesk - Oct 2, 2023, 7:32AM
- Vistagen Therapeutics Also Planning To Initiate A Palisade Phase 2 Re-dosing Trial In 2H Of 2024 - 8KBenzinga Newsdesk - Oct 2, 2023, 7:21AM
- Vistagen Therapeutics Plans To Launch The Palisade-3 Trial In 1H Of 2024 And Palisade-4 In 2H Of 2024 - 8KBenzinga Newsdesk - Oct 2, 2023, 7:20AM
Tuesday, September 12, 2023
Monday, September 11, 2023
Tuesday, September 05, 2023
- Maxim Group Maintains Buy on Vistagen Therapeutics, Maintains $30 Price TargetBenzinga Newsdesk - Sep 5, 2023, 3:35PM
- 10 Short Squeeze Stocks To Watch: Blue Apron, Getty Images, Black Rifle Coffee And MoreChris Katje - Sep 5, 2023, 9:35AM
- Vistagen, Fuji Enter Exclusive Negotiation Agreement For Potential License To Develop, Commercialize Vistagen's Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, In Japan; Vistagen To Receive $1.5MBenzinga Newsdesk - Sep 5, 2023, 9:03AM
Monday, August 28, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
- VistaGen Therapeutics Q1 EPS $(0.94) Up From $(3.00) YoY, Sales $117.00K Down From $310.10K YoYBenzinga Newsdesk - Aug 10, 2023, 4:24PM
- Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Aug 10, 2023, 1:17PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Aug 10, 2023, 9:06AM
- AffaMed Therapeutics Announces Partner Vistagen Reports Top-Line Results From Phase 3 PALISADE-2 Trial Of Fasedienol Nasal Spray In Social Anxiety DisorderHappy Mohamed - Aug 10, 2023, 9:02AM
- Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 10, 2023, 8:06AM
- $18M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are BuyingLisa Levin - Aug 10, 2023, 6:59AM
- Earnings Scheduled For August 10, 2023Benzinga Insights - Aug 10, 2023, 6:59AM
Wednesday, August 09, 2023
Tuesday, August 08, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Aug 8, 2023, 1:31PM
- Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Aug 8, 2023, 1:13PM
- VistaGen Therapeutics Shares Resume TradeHappy Mohamed - Aug 8, 2023, 9:56AM
- VistaGen Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down -23.8%Happy Mohamed - Aug 8, 2023, 9:51AM
- What's Going On With VistaGen Therapeutics Stock?Adam Eckert - Aug 8, 2023, 9:35AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Aug 8, 2023, 9:06AM